| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | MYLK3 Blocking Peptide for STJ501841 is synthetically produced from the 10-60 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | MYLK3 |
| Gene ID: | 91807 |
| Uniprot ID: | MYLK3_HUMAN |
| Immunogen Region: | 10-60 |
| Specificity: | This blocking peptide is recommended for use in combination with MYLK3 antibody, STJ501841 |
| Immunogen: | Synthetic peptide taken within amino acid region 10-60 on human Myosin light chain kinase 3 protein. |
| Tissue Specificity | Restricted to heart. |
| Post Translational Modifications | Phosphorylated on serine residues. |
| Function | Kinase that phosphorylates MYL2 in vitro. Promotes sarcomere formation in cardiomyocytes and increases cardiomyocyte contractility. |
| Peptide Name | Myosin Light Chain Kinase 3Cardiac-Mybp-C-Associated Ca/Cam KinaseCardiac-Mlck |
| Cellular Localisation | Cytoplasm |
| Alternative Peptide Names | Myosin Light Chain Kinase 3 proteinCardiac-Mybp-C-Associated Ca/Cam Kinase proteinCardiac-Mlck proteinMYLK3 proteinMLCK protein |
Information sourced from Uniprot.org